Philips CEO Sees First Quarter as Solid Start for Year

The video discusses the 2017 economic outlook, focusing on sales growth targets and the impact of healthcare policy changes, particularly the Affordable Care Act. It highlights Phillips' focus on health technology innovations, such as the Asurion platform and intelli sprays, which aim to improve clinical outcomes. The video also addresses concerns about policy changes under the Trump administration and their impact on the healthcare market, emphasizing the importance of partnerships for value-based care. Lastly, it covers the limited impact of issues in Phillips' defibrillator business.

What was Phillips' sales growth target for the year 2017?

• 4-6%

• 6-8%

• 2-3%

• 8-10%

Which market was described as flattish due to the Accountable Care Act?

• India

• United States

• China

• Europe

What was a major concern for customers regarding healthcare policy changes?

• Lack of medical staff

• Rising healthcare costs

• Insurance cuts

• Increased taxes

What is the purpose of Phillips' Asurion minimally invasive surgery platform?

• To allow same-day discharge

• To reduce surgery costs

• To increase surgery speed

• To improve surgery accuracy

What was the order growth percentage for Phillips' diagnosis and treatment portfolio in the first quarter?

• 6%

• 5%

• 4%

• 3%

How did Phillips view the impact of the defibrillator business on its overall performance?

• Not very significant

• Moderately significant

• Highly significant

• Extremely significant

What was the estimated revenue size of Phillips' defibrillator business?

• $100 million

• $200 million

• $150 million

• $50 million